PT - JOURNAL ARTICLE AU - P. Tupper AU - H. Boury AU - M. Yerlanov AU - C. Colijn TI - Event-specific interventions to minimize COVID-19 transmission AID - 10.1101/2020.07.09.20149435 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.09.20149435 4099 - http://medrxiv.org/content/early/2020/07/10/2020.07.09.20149435.short 4100 - http://medrxiv.org/content/early/2020/07/10/2020.07.09.20149435.full AB - Coronavirus disease 2019 (COVID-19) is a global pandemic with over 11 million cases worldwide. Currently there is no treatment and no vaccine. Interventions such as hand washing, masks, social distancing, and “social bubbles” are used to limit community transmission, but it is challenging to choose the best interventions for a given activity. Here, we provide a quantitative framework to determine which interventions are likely to have the most impact in which settings. We introduce the concept of “event R”, the expected number of new infections due to the presence of a single infected individual at an event. We obtain a fundamental relationship between event R and four parameters: transmission intensity, duration of exposure, the proximity of individuals, and the degree of mixing. We use reports of small outbreaks to establish event R and transmission intensity in a range of settings. We identify principles that guide whether physical distancing, masks and other barriers to transmission, or social bubbles will be most effective. We outline how this information can be obtained and used to re-open economies with principled measures to reduce COVID-19 transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPT, CC and MY were supported by Natural Science and Engineering Research Council (Canada) Discovery Grants (RGPIN-2019-06911 and RGPIN-2019-06624). CC receives funding from the Federal Government of Canada's Canada 150 Research Chair program and from Genome BC (COV-142). No author received payment or services from any third party for any aspect of this work. Funders had no role in the study design, preparation or analysis.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available at the links given in the text.